Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2026-05-25 @ 8:06 PM
Study NCT ID:
NCT05312918
Status:
UNKNOWN
Last Update Posted:
2022-04-06
First Post:
2021-09-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: